Literature DB >> 2180373

Monoclonal antibody to type F Clostridium botulinum toxin.

J L Ferreira1, M K Hamdy, S G McCay, F A Zapatka.   

Abstract

Hybridomas synthesizing monoclonal antibodies (MAbs) against type F Clostridium botulinum toxin were developed. MAb from one stable hybridoma, hybridoma 223, consisted of kappa light chains and an immunoglobulin G subclass 2a heavy chain. This MAb was used in a double-sandwich enzyme-linked immunosorbent assay to detect type F toxin in foods, culture fluids, and purified toxin preparations. The sensitivity of the double-sandwich enzyme-linked immunosorbent assay was approximately 10 mouse lethal doses of toxin per ml of toxic fluid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180373      PMCID: PMC183425          DOI: 10.1128/aem.56.3.808-811.1990

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  9 in total

1.  Preliminary report on the isolation of an apparently new type of CI. botulinum.

Authors:  V MOLLER; I SCHEIBEL
Journal:  Acta Pathol Microbiol Scand       Date:  1960

2.  The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.

Authors:  S Kozaki; Y Kamata; T Nagai; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Radioimmunoassay for type A toxin of Clostridium botulinum.

Authors:  D A Boroff; G Chu-Chen
Journal:  Appl Microbiol       Date:  1973-04

5.  Detection of botulinal toxins by immunodiffusion.

Authors:  B L Vermilyea; H W Walker; J C Ayres
Journal:  Appl Microbiol       Date:  1968-01

6.  Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.

Authors:  K Oguma; T Agui; B Syuto; K Kimura; H Iida; S Kubo
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  The enzyme-linked immunosorbent assay (ELISA) for the detection and determination of Clostridium botulinum toxins A, B, and E.

Authors:  S Notermans; A M Hagenaars; S Kozaki
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

8.  Purification and properties of Clostridium botulinum type F toxin.

Authors:  K H Yang; H Sugiyama
Journal:  Appl Microbiol       Date:  1975-05

9.  Monoclonal antibody for the detection of Clostridium botulinum type A toxin.

Authors:  J L Ferreira; M K Hamdy; Z L Herd; S G McCay; F A Zapatka
Journal:  Mol Cell Probes       Date:  1987-12       Impact factor: 2.365

  9 in total
  2 in total

1.  PCR and gene probe identification of botulinum neurotoxin A-, B-, E-, F-, and G-producing Clostridium spp. and evaluation in food samples.

Authors:  P Fach; M Gibert; R Griffais; J P Guillou; M R Popoff
Journal:  Appl Environ Microbiol       Date:  1995-01       Impact factor: 4.792

Review 2.  The evolving field of biodefence: therapeutic developments and diagnostics.

Authors:  James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.